XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Material Agreements (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended
--- | --- | --- | ---
Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017
Supplemental Agreement [Abstract] |  |  |  |  |
Revenues |  | $ 13,267 | $ 27,146 | $ 50,606 | $ 54,723
License and Royalty Revenue [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Revenues |  | 3,355 | $ 17,351 | $ 17,387 | 22,820
Commercial Exploitation Agreement with Indivior [Member] |  |  |  |  |
Commercial Exploitation Agreement [Abstract] |  |  |  |  |
License agreement term |  |  |  | 7 years |
Automatic renewal period of agreement |  |  |  | 1 year |
Commercial Exploitation Agreement with Indivior [Member] | Minimum [Member] |  |  |  |  |
Commercial Exploitation Agreement [Abstract] |  |  |  |  |
Notice period of intent not to renew agreement |  |  |  | 1 year |
Supplemental Agreement with Indivior [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Receivable, Issuance of process patent rights |  | 2,500 |  | $ 2,500 |
Supplemental Agreement with Indivior [Member] | Maximum [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Receivable, Additional amounts |  | 41,500 |  | 41,500 |
Receivable, Milestone payments and royalties |  | 39,000 |  | 39,000 |
Receivable, Issuance of process patent rights |  | 75,000 |  | 75,000 |
Supplemental Agreement with Indivior [Member] | License and Royalty Revenue [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Revenues | $ 17,000 | 3,000 |  | 16,500 |
License Agreement with Sunovion Pharmaceuticals, Inc. [Member] |  |  |  |  |
License Agreement [Abstract] |  |  |  |  |
Revenues, Milestone revenues recognized |  |  |  | 0 | 5,000
License Agreement with Sunovion Pharmaceuticals, Inc. [Member] | Maximum [Member] |  |  |  |  |
License Agreement [Abstract] |  |  |  |  |
Remaining milestone payments, Regulatory events |  | 11,000 |  | 11,000 |
Remaining milestone payments, Commercial events |  | $ 20,000 |  | 20,000 |
Collaboration and License Agreement with Mitsubishi Tanabe [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Revenues |  |  |  | 240 |
Agreement to Terminate CLA with KemPharm [Member] |  |  |  |  |
Supplemental Agreement [Abstract] |  |  |  |  |
Revenues |  |  |  | $ 0 | $ 0

X
- Definition Potential additional payments receivable under the agreement, relating to issuance of additional process patent rights as of the balance sheet date. + References No definition available. + Details
Name: | aqst_AdditionalPaymentReceivableFromIssuanceOfProcessPatentRights
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Period for which the agreement is renewed automatically. + References No definition available. + Details
Name: | aqst_AutomaticRenewalPeriodOfAgreement
Namespace Prefix: | aqst_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | aqst_CommercialExploitationAgreementAbstract
Namespace Prefix: | aqst_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | aqst_LicenseAgreementAbstract
Namespace Prefix: | aqst_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition License agreement term period. + References No definition available. + Details
Name: | aqst_LicenseAgreementTerm
Namespace Prefix: | aqst_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Notice period of intent not to renew agreement, prior to the expiration of the initial or renewal term. + References No definition available. + Details
Name: | aqst_NoticePeriodForNotToRenewAgreement
Namespace Prefix: | aqst_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential additional payment receivable under the agreement as of the balance sheet date. + References No definition available. + Details
Name: | aqst_ReceivableAdditionalAmounts
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Potential additional payments receivable under the agreement, relating to milestones and royalties as of the balance sheet date. + References No definition available. + Details
Name: | aqst_ReceivableMilestonePaymentsAndRoyalties
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Commercial milestone events receivable, that are contingent on the achievement of certain sales levels. + References No definition available. + Details
Name: | aqst_RemainingMilestonePaymentCommercialEvents
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Remaining milestone payment received for regulatory events as of the balance sheet date. + References No definition available. + Details
Name: | aqst_RemainingMilestonePaymentRegulatoryEvents
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | aqst_SupplementalAgreementAbstract
Namespace Prefix: | aqst_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References No definition available. + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aqst_CollaborationAndLicenseAgreementWithMitsubishiTanabeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aqst_AgreementToTerminateCLAWithKemPharmMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |